The global cell dissociation market is likely to boost due to the growing demand for cancer research, increased biomedical applications, and reduction in cost and time.
The global cell dissociation market size was valued at USD 230.2 million in 2019 and projected to reach USD 546 million by 2027, growing at a CAGR of 12.1% during the forecast period, 2020-2027. It is due to the surge in demand for enzymatic dissociation products and instruments by the end-users. Further, the increasing applications of cell dissociation technological advancements and the use of advanced devices in cell biology and tissue engineering will augment the growth of the global cell dissociation industry in the forecast periods. Additionally, the increasing R&D investment in the life science research industry and rising demand for regenerative medicines are expected to foster global market growth. With the development of cell dissociation products and the increase in people’s medical consumption, expenditure will bolster the growth of global cell dissociation market share in the coming years. Moreover, the government’s interference in improving healthcare infrastructure and swelling investments in the R&D sector will stimulate the market share. Furthermore, the increasing government funding for cancer research and rising research on chronic diseases will accelerate the growth of the global cell dissociation industry.
Product Overview in the Global Cell Dissociation Market
Based on the product, the global cell dissociation market is segregated into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories. The non-enzymatic dissociation products segment is estimated to witness the highest growth over the analysis timeframe due to growing demand for animal origin free cell dissociation and increasing research in stem cell research.
Tissue Overview in the Global Cell Dissociation Market
The global cell dissociation market is categorized into connective tissue, epithelial tissue, and other tissue based on the tissue. The connective tissue segment is held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the increasing research in the field of cancer.
Type Overview in the Global Cell Dissociation Market
Based on the type, the global cell dissociation market is classified into tissue dissociation and cell detachment.
The tissue disassociation is expected to be the highest revenue share for cell dissociation during the forecast period. The segment’s growth is primarily attributed to the high adoption in a wide range of application areas, including stem cell, tissue culture, and cell biology research.
End-User Overview in the Global Cell Dissociation Market
Based on the end-user, the global cell dissociation market is segmented into pharmaceutical & biotechnological companies, research & academic institutes, and other end users. The pharmaceutical and biotechnology companies centers segment will dominate the global cell dissociation market by 2027. It is due to the high adoption of enzymatic dissociation products & instruments, rising R&D investments, and an increasing number of pharmaceutical industries.
Region Overview in the Global Cell Dissociation Market
The global cell dissociation market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa by geography. North America is estimated to project considerable growth over 2020-2026. It is due to key market players’ presence, increasing focus on continuous product innovation, and rising public & private funding for cancer research.
The Asia Pacific will maintain a prominent share of the cell dissociation market by 2027. It is due to the increasing research on chronic disease and growing pharmaceutical infrastructure in emerging countries such as India and China.
Global Cell Dissociation Market: Competitive Landscape
Companies such as GE Healthcare, Stemcell Technologies, Thermo Fisher Scientific, Roche Holding AG, Bacton Dickinson and Company, MiltenyiBiotec, HiMedia Laboratories, and PAN-Biotech are the key players in the global cell dissociation market.